CTOR 8-K 2026-09-29
CITIUS ONCOLOGY, INC. (CTOR) 8-K dated 2026-09-29 — accession 0001213900-26-104694.
CITIUS ONCOLOGY, INC. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
CITIUS ONCOLOGY, INC. filed a 8-K on 2026-09-29. Accession 0001213900-26-104694.
This 8-K covers: Shareholder vote results (Item 5.07). SEC EDGAR holds the official filing and its exhibits.
Latest reported CTOR revenue for 2026-06-30 was $1.5M. Net income was -$8.9M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. CTOR currently screens at market cap $105.2M.
Not investment advice. The CTOR SEC hub lists recent forms. The stock page is the research view.